| abstract |
Novel diaminothiazoles are selective inhibitors of Cdk4. The compounds, and pharmaceutically acceptable salts and esters thereof, are antiproliferative agents useful for the treatment or control of solid tumors, particularly breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds and intermediates useful in the preparation of these compounds. |